Martha J. Demski
Known title: DirectorCIK: 0001198230
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
ADMA Biologics Draws Investor Attention Amid Market Decline. Recent reports indicate that ADMA Biologics is attracting investor attention and showing relative strength while the broader market declines. Analysts have expressed optimism, with an average price target of $17.00, which is well above the current trading range. This suggests that some market participants view the stock as undervalued relative to its long-term potential, despite recent volatility.
Transaction History
| TKNO | ▼ Sell | Other | 12,000 | $0 | 7/14/2026 | View on chart |
| TKNO | ▼ Sell | Other | 12,000 | $0 | 7/14/2026 | View on chart |
| TKNO | ▼ Sell | Open Market | 8,000 | $41K | 6/27/2025 | View on chart |
| TKNO | ▲ Buy | Grant | 54,300 | $0 | 6/17/2025 | View on chart |
| TKNO | ▲ Buy | Grant | 20,000 | $0 | 6/26/2024 | View on chart |
| ADMA | ▲ Buy | Grant | 25,815 | $0 | 3/6/2023 | View on chart |
| ADMA | ▲ Buy | Grant | 26,586 | $0 | 3/7/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
Alpha Teknova Shares Rise 7.1% Amid Technical Momentum
Alpha Teknova stock moved 7.1% higher recently, a gain that has raised questions about the sustainability of this strength. The move coincides with a Bollinger Band breakout signal, indicating increased volatility and momentum. While the stock is trading well above its recent support levels, the rapid rise has pushed the RSI into overbought territory, suggesting the pace of gains may be intense.
Alpha Teknova Shares Rise 7.1% Amid Technical Momentum. Alpha Teknova stock moved 7.1% higher recently, a gain that has raised questions about the sustainability of this strength. The move coincides with a Bollinger Band breakout signal, indicating increased volatility and momentum. While the stock is trading well above its recent support levels, the rapid rise has pushed the RSI into overbought territory, suggesting the pace of gains may be intense.